There are currently 1.9 billion people who are
overweight and 800 million who suffer from obesity. Those who live with this health
problem are twice as likely to suffer complications that require
hospitalization if they are infected with COVID-19. People who suffer from
obesity have a triple risk of suffering from metabolic syndrome, and this risk
is multiplied up to 8 times if they have been obese since childhood.
It is essential to raise awareness of this problem
regarding obesity, especially because 54% of the world population under the age
of 16 is overweight.
Obesity is a physiopathology consisting of an excess
of adipose tissue that accumulates in a way that is hazardous to health.
Obesity is diagnosed by measuring certain parameters:
BMI (body mass index): This measurement
is calculated by dividing the weight in kilograms by the height in meters
squared.
It’s estimated that a BMI between 19 and 24 is “normal
weight”, between 25 and 35 means overweight, and greater than 35 means obesity.
This parameter is only valid for middle-aged adults,
as it has been used since the beginning of the 19th century as a
statistical measure but not as an indicator of the adipose tissue of a person. In
fact, it was not until 1985 that it was established as a diagnostic factor,
when obesity became a public health problem worldwide, even more so than
malnutrition in poor countries.
Due to the limitations of this value in identifying
obesity, the waist-hip ratio (WHR) and the percentage of fatty
tissue are also currently measured through techniques like axial
tomography or bioimpedance.
For men, a waist circumference of 102 cm and 30% fat
in relation to body weight is considered overweight, and for women, a waist
circumference of 88 cm and 40% fat mass.
Obesity is not an esthetic problem, since 80% of
people suffering from it have a relevant predisposition to suffer from these
disorders: cardiovascular diseases such as hypertension or dyslipidemia,
resistance to insulin and type 2 diabetes, cognitive impairment, sleep disorders
(including sleep apnea), urinary incontinence, sexual dysfunction,
osteoarthritis, cancer and a higher prevalence of falls after the age of 65.
The risk of comorbidity for these people is even
greater when they have been overweight since childhood.
For all these reasons, obesity is a problem and a
challenge for health that involves changing dietary habits but also must be
dealt with in a multifactorial way by understanding that it is a determining
cause of a significant number of pathologies.
In 1996, the term “sarcopenic obesity” was
coined, designating a disease in which a person has a reduced amount of lean
mass (i.e., muscle quality) in relation to the amount of fatty tissue. This
means that there are people who, due to a sedentary lifestyle and poor diet,
although they have a suitable or even low BMI, have a high percentage of fat
due to an excessive deterioration of the muscle mass.
This disease is increasingly affecting young people
but is especially typical in people over 65 years of age.
Sarcopenic obesity entails the same problems as
excessive fat accumulation, but its diagnosis is more difficult, and its
relevance as a health problem is socially underestimated.
This is a new challenge to tackle since there are already
more than 700 million inhabitants older than 65 in the world.
Obesity is a multifactorial problem, and therefore the
way we deal with it should also be multifactorial.